ATE323492T1 - Piperazin- und homopiperazinderivate zur hemmung der zellenadhäsion und zelleninfiltration - Google Patents

Piperazin- und homopiperazinderivate zur hemmung der zellenadhäsion und zelleninfiltration

Info

Publication number
ATE323492T1
ATE323492T1 AT96118463T AT96118463T ATE323492T1 AT E323492 T1 ATE323492 T1 AT E323492T1 AT 96118463 T AT96118463 T AT 96118463T AT 96118463 T AT96118463 T AT 96118463T AT E323492 T1 ATE323492 T1 AT E323492T1
Authority
AT
Austria
Prior art keywords
piperazine
cell adhesion
cell
agent
inhibiting
Prior art date
Application number
AT96118463T
Other languages
English (en)
Inventor
Hiroshi Nakao
Michihisa Umetani
Makoto Suda
Takao Nagoya
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE323492T1 publication Critical patent/ATE323492T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT96118463T 1995-11-20 1996-11-18 Piperazin- und homopiperazinderivate zur hemmung der zellenadhäsion und zelleninfiltration ATE323492T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30152695A JP3808921B2 (ja) 1995-11-20 1995-11-20 細胞接着阻害剤

Publications (1)

Publication Number Publication Date
ATE323492T1 true ATE323492T1 (de) 2006-05-15

Family

ID=17897999

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96118463T ATE323492T1 (de) 1995-11-20 1996-11-18 Piperazin- und homopiperazinderivate zur hemmung der zellenadhäsion und zelleninfiltration

Country Status (5)

Country Link
US (1) US5723465A (de)
EP (1) EP0774257B1 (de)
JP (1) JP3808921B2 (de)
AT (1) ATE323492T1 (de)
DE (1) DE69636048T2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4388228B2 (ja) * 1998-02-19 2009-12-24 興和株式会社 環状アミド化合物
US6432957B1 (en) * 2001-06-29 2002-08-13 Kowa Co., Ltd. Piperazine derivative
US6472386B1 (en) * 2001-06-29 2002-10-29 Kowa Co., Ltd. Cyclic diamine compound with 5-membered ring groups
US6509329B1 (en) 2001-06-29 2003-01-21 Kowa Co., Ltd. Cyclic diamine compound with 6-membered ring groups
US6552188B2 (en) * 2001-06-29 2003-04-22 Kowa Co., Ltd. Unsymmetrical cyclic diamine compound
US6632810B2 (en) * 2001-06-29 2003-10-14 Kowa Co., Ltd. Cyclic diamine compound with condensed-ring groups
US6867221B2 (en) * 2001-08-30 2005-03-15 Kowa Co., Ltd. Cyclic amine compounds and pharmaceutical composition containing the same
US6605620B1 (en) 2001-08-30 2003-08-12 Kowa Co., Ltd. Cyclic amine compounds and pharmaceutical composition containing the same
US6395753B1 (en) * 2001-08-30 2002-05-28 Kowa Co., Ltd. Cyclic amine compounds and pharmaceutical composition containing the same
MY134200A (en) * 2002-04-12 2007-11-30 Kowa Co Method for treating cancer
AU2003243010A1 (en) * 2002-06-28 2004-01-19 Kowa Co., Ltd. Erythropoietin production potentiator
AU2003272972A1 (en) * 2002-10-11 2004-05-04 Kowa Co., Ltd. Method of treatment for cancer
AU2003280558A1 (en) * 2002-10-11 2004-05-04 Kowa Co., Ltd. Method for treatment of cancer
WO2004032931A1 (ja) * 2002-10-11 2004-04-22 Kowa Co., Ltd. 癌の処置方法
JP6026413B2 (ja) * 2011-06-23 2016-11-16 学校法人自治医科大学 プロテアソーム阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5732255A (en) * 1980-08-05 1982-02-20 Kowa Co Trimethoxyphenyl derivative
JP2722250B2 (ja) * 1989-05-30 1998-03-04 興和株式会社 新規なジアミン化合物及びこれを含有する脳機能障害改善剤

Also Published As

Publication number Publication date
DE69636048T2 (de) 2006-08-31
EP0774257A3 (de) 1997-08-27
JPH09143075A (ja) 1997-06-03
JP3808921B2 (ja) 2006-08-16
EP0774257B1 (de) 2006-04-19
EP0774257A2 (de) 1997-05-21
US5723465A (en) 1998-03-03
DE69636048D1 (de) 2006-05-24

Similar Documents

Publication Publication Date Title
BE2018C008I2 (de)
DE69636048D1 (de) Piperazin- und Homopiperazinderivate zur Hemmung der Zellenadhäsion und Zelleninfiltration
TR200000065T2 (tr) Epotilon türevleri.
CY2488B1 (en) New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for trea.
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
MX9604398A (es) Derivados de sulfonamida.
MY128323A (en) Thiazole derivatives for inhibition of cytokine production and of cell adhesion
PE34996A1 (es) Nuevo derivado de pirrocarbazol
ATE231128T1 (de) Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung
ATE232528T1 (de) Pyrimidinylpyrazolderivate
ATE14880T1 (de) Cephalosporinverbindungen und ihre herstellung.
EP0335979A4 (en) Thienopyrimidine derivatives
NZ337362A (en) Heterocyclically substituted piperidyl-amino-indan-1-ol compounds and uses thereof
DE69906243D1 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
DE69624459D1 (de) Kondensierte indan-derivate und ihre salze
DK0963998T3 (da) Azasteroidforbindelse til behandling eller prævention af prostatacancer
SG50820A1 (en) Novel thiouracil derivatives and metal surface- treating agent comprising thereof
EP1072582A4 (de) Intermediate in der synthese einer ringeinheit der in position 2 substituierten vitamin d derivate
ES8705363A1 (es) Un procedimiento para preparar derivados de tetrahidronaftaleno
CA2202031A1 (en) Condensed indan derivatives and salts thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties